Sevoflurane vs Propofol Effect on Endothelial Damage Markers After Knee Ligament Surgery.
Primary Purpose
Ischemia Reperfusion Injury
Status
Completed
Phase
Not Applicable
Locations
Chile
Study Type
Interventional
Intervention
Sevoflurane
Propofol
Sponsored by
About this trial
This is an interventional prevention trial for Ischemia Reperfusion Injury focused on measuring Syndecan-1, Heparan sulfate, Thrombomodulin, Ischemia Reperfusion, Anesthesia
Eligibility Criteria
Inclusion Criteria:
- American Society of Anesthesiologists Classification (ASA Class) I and II
- Elective knee ligament surgery
- Use of a femoral tourniquet
Exclusion Criteria:
- Allergies to egg or soya
- Previous history of critical events during surgery and perioperative period
- Patients at risk of hyperthermia malignant
- Patients with 3 or more predictor of difficult airway management
Sites / Locations
- Hospital Clínico de la Universidad de Chile
Arms of the Study
Arm 1
Arm 2
Arm Type
Active Comparator
Experimental
Arm Label
Propofol
Sevoflurane
Arm Description
After spinal anesthesia, patients in this arm will receive an intravenous target controlled infusion to site effect (TCI/Ce) infusion of propofol to achieve hypnosis guided to a bispectral index (BIS) level of 40-60 during surgery.
After spinal anesthesia, patients in this arm will receive an inhalation induction with sevoflurane to achieve hypnosis guided to 0.7-0.9 minimum alveolar concentration (MAC) during surgery.
Outcomes
Primary Outcome Measures
Syndecan-1 levels
Differences in the concentration of syndecan-1 in blood serum during and after surgery
Secondary Outcome Measures
Heparan sulfate levels
Differences in the concentration of heparan sulfate in blood serum during and after surgery
Thrombomodulin
Differences in the concentration of thrombomodulin in blood serum during and after surgery
Full Information
NCT ID
NCT03772054
First Posted
December 9, 2018
Last Updated
December 11, 2019
Sponsor
University of Chile
1. Study Identification
Unique Protocol Identification Number
NCT03772054
Brief Title
Sevoflurane vs Propofol Effect on Endothelial Damage Markers After Knee Ligament Surgery.
Official Title
Sevoflurane vs Propofol Effect on Endothelial Damage Markers After Knee Ligament Surgery. A Randomized Controlled Trial
Study Type
Interventional
2. Study Status
Record Verification Date
December 2019
Overall Recruitment Status
Completed
Study Start Date
December 20, 2018 (Actual)
Primary Completion Date
December 11, 2019 (Actual)
Study Completion Date
December 11, 2019 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of Chile
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
Endothelial damage has been reported after ischemia-reperfusion events. This can be characterized by measurements of glycocalyx and endothelial components that are released to blood after the insult. Sevoflurane and inhaled anesthetic commonly used for surgery have shown protective endothelial effects in animal and in-vitro models. Knee-ligament surgery with the use of a femoral tourniquet generates a transient ischemia-reperfusion (IR) state after the tourniquet is released. This research aims to compare the effect of sevoflurane and propofol in the release of glycocalyx and endothelial biomarkers after IR in this surgical scenario.
Detailed Description
To study the anesthetics effect on the endothelial damage induced by Ischemia-reperfusion (IR) in knee-ligament surgery, we will perform a randomized controlled clinical trial comparing the concentrations of syndecan-1 and heparan sulfate, both markers of superficial glycocalyx shedding and the concentration of thrombomodulin, a marker of endothelial cell damage, in serum of patients under hypnosis with sevoflurane or propofol after a spinal anesthesia.
After ethical review board approval and patients consent, 16 subjects (8 per group) scheduled for Knee-ligament replacement will be randomly allocated in one of the two parallel arms of the study. All patients will enter the operating room and after standard ASA monitorization and placement of an intravenous line (IV), a spinal anesthesia will be performed under midazolam sedation. After analgesia and motor block establishment, an intravenous or inhalation hypnosis induction will be performed (according to the study arm allocation). The airway will be secured by a laryngeal mask placement and the surgery will be started. A femoral tourniquet will be installed and inflated by surgeon indication at 100-120 mmHg over patient systolic blood pressure. Blood samples to measure endothelial damage biomarkers will be taken in five different moments to follow concentration changes before and after the IR insult. Fluid and drugs administration will be standardized.
Venous blood samples will be collected at the moment of IV placement (baseline values), during surgery before of tourniquet release (TR), 10, 60 and 90 min minutes after TR. After obtaining all samples, serum syndecan-1, heparan sulfate, and thrombomodulin will be measured by a researcher blinded to patient allocation using commercial available Elisa kits. The concentration of each biomarker at each sample time will be compared.
A sample size calculation was performed based on a few clinical reports to detect a 25% reduction in the mean concentration of syndecan-1 in the sevoflurane group with an alpha of 0,05 and a power of 80%. Then 16 patients (8 patients per arm) will be enrolled for a two-sides test analysis.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Ischemia Reperfusion Injury
Keywords
Syndecan-1, Heparan sulfate, Thrombomodulin, Ischemia Reperfusion, Anesthesia
7. Study Design
Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Outcomes Assessor
Masking Description
Blood samples will be codified by the principal investigator. Laboratory team will receive all samples for biomarkers measures. Results will be analyzed by the principal investigator.
Allocation
Randomized
Enrollment
16 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Propofol
Arm Type
Active Comparator
Arm Description
After spinal anesthesia, patients in this arm will receive an intravenous target controlled infusion to site effect (TCI/Ce) infusion of propofol to achieve hypnosis guided to a bispectral index (BIS) level of 40-60 during surgery.
Arm Title
Sevoflurane
Arm Type
Experimental
Arm Description
After spinal anesthesia, patients in this arm will receive an inhalation induction with sevoflurane to achieve hypnosis guided to 0.7-0.9 minimum alveolar concentration (MAC) during surgery.
Intervention Type
Drug
Intervention Name(s)
Sevoflurane
Intervention Description
Inhalation anesthetic agent
Intervention Type
Drug
Intervention Name(s)
Propofol
Intervention Description
Intravenous anesthetic agent
Primary Outcome Measure Information:
Title
Syndecan-1 levels
Description
Differences in the concentration of syndecan-1 in blood serum during and after surgery
Time Frame
At the moment of IV placement (baseline values), during surgery before of tourniquet release (TR), 10, 60 and 90 min minutes after TR
Secondary Outcome Measure Information:
Title
Heparan sulfate levels
Description
Differences in the concentration of heparan sulfate in blood serum during and after surgery
Time Frame
At the moment of IV placement (baseline values), during surgery before of tourniquet release (TR), 10, 60 and 90 min minutes after TR
Title
Thrombomodulin
Description
Differences in the concentration of thrombomodulin in blood serum during and after surgery
Time Frame
At the moment of IV placement (baseline values), during surgery before of tourniquet release (TR), 10, 60 and 90 min minutes after TR
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
60 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
American Society of Anesthesiologists Classification (ASA Class) I and II
Elective knee ligament surgery
Use of a femoral tourniquet
Exclusion Criteria:
Allergies to egg or soya
Previous history of critical events during surgery and perioperative period
Patients at risk of hyperthermia malignant
Patients with 3 or more predictor of difficult airway management
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Felipe Maldonado, M.D., M.Sc.
Organizational Affiliation
Hospital Clìnico de la Universidad de Chile.
Official's Role
Principal Investigator
Facility Information:
Facility Name
Hospital Clínico de la Universidad de Chile
City
Independencia
State/Province
Santiago
ZIP/Postal Code
8380456
Country
Chile
12. IPD Sharing Statement
Plan to Share IPD
No
Citations:
PubMed Identifier
32434495
Citation
Maldonado F, Morales D, Gutierrez R, Barahona M, Cerda O, Caceres M. Effect of sevoflurane and propofol on tourniquet-induced endothelial damage: a pilot randomized controlled trial for knee-ligament surgery. BMC Anesthesiol. 2020 May 20;20(1):121. doi: 10.1186/s12871-020-01030-w.
Results Reference
derived
Learn more about this trial
Sevoflurane vs Propofol Effect on Endothelial Damage Markers After Knee Ligament Surgery.
We'll reach out to this number within 24 hrs